Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 353K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nishimura, T. Articles by Ohta, A. Search for Related Content PubMed PubMed Citation Articles by Nishimura, T. Articles by Ohta, A. Social Bookmarking                            What's this?

Original Article

^a From the Section of Genetic Engineering, Research Center for Genetic Engineering and Cell Transplantation
^b Department of Immunology, Tokai University School of Medicine, Isehara 259-1193, Japan
^c BioScience Research Laboratory, Fujiya Co. Ltd., Hadano 257, Japan
Section of Bacterial Infection, Institute of Immunological Science, Hokkaido University, Sapporo 060-0815, Japan.81-11-707-683581-11-706-5521

The role of T helper type 1 (Th1) and Th2 cells in tumor immunity was investigated using Th cells induced from ovalbumin (OVA)-specific T cell receptor transgenic mice. Although Th1 cells exhibited stronger cytotoxicity than Th2 cells, both cell types completely eradicated tumors when transferred into mice bearing A20 tumor cells transfected with the OVA gene (A20-OVA). Th1 cells eradicated the tumor mass by inducing cellular immunity, whereas Th2 cells destroyed the tumor by inducing tumor necrosis. Both Th1 and Th2 cells required CD8⁺ T cells to eliminate tumors, and neither of these cells were able to completely eliminate A20-OVA tumors from T and B cell–deficient RAG2^–/– mice. Mice cured from tumors by Th1 and Th2 cell therapy rejected A20-OVA upon rechallenge, but CD8⁺ cytotoxic T lymphocytes were induced only from spleen cells prepared from cured mice by Th1 cell therapy. Moreover, we demonstrated that Th1 and Th2 cells used distinct adhesion mechanisms during tumor eradication: the leukocyte function-associated antigen (LFA)-1–dependent cell–cell adhesion step was essential for Th1 cell therapy, but not for Th2 cell therapy. These findings demonstrated for the first time the distinct role of antigen-specific Th1 and Th2 cells during eradication of established tumors in vivo.

Key Words: Th1 • Th2 • tumor • adoptive immunotherapy • cytokine

© 1999 The Rockefeller University Press

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., Sitkovsky, M. (2009). A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments. J. Immunol. 183: 5487-5493 [Abstract] [Full Text]  
• Ziegler, A., Heidenreich, R., Braumuller, H., Wolburg, H., Weidemann, S., Mocikat, R., Rocken, M. (2009). EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion. Blood 113: 3494-3502 [Abstract] [Full Text]  
• Nagahara, K., Arikawa, T., Oomizu, S., Kontani, K., Nobumoto, A., Tateno, H., Watanabe, K., Niki, T., Katoh, S., Miyake, M., Nagahata, S.-I., Hirabayashi, J., Kuchroo, V. K., Yamauchi, A., Hirashima, M. (2008). Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions. J. Immunol. 181: 7660-7669 [Abstract] [Full Text]  
• Tassi, E., Gavazzi, F., Albarello, L., Senyukov, V., Longhi, R., Dellabona, P., Doglioni, C., Braga, M., Di Carlo, V., Protti, M. P. (2008). Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients. J. Immunol. 181: 6595-6603 [Abstract] [Full Text]  
• Finke, J. H., Rini, B., Ireland, J., Rayman, P., Richmond, A., Golshayan, A., Wood, L., Elson, P., Garcia, J., Dreicer, R., Bukowski, R. (2008). Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients. Clin. Cancer Res. 14: 6674-6682 [Abstract] [Full Text]  
• Chiang, C. L-L., Ledermann, J. A., Aitkens, E., Benjamin, E., Katz, D. R., Chain, B. M. (2008). Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor. Clin. Cancer Res. 14: 4898-4907 [Abstract] [Full Text]  
• Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., Gattinoni, L., Wrzesinski, C., Hinrichs, C. S., Kerstann, K. W., Feigenbaum, L., Chan, C.-C., Restifo, N. P. (2008). Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373 [Abstract] [Full Text]  
• Kalli, K. R., Krco, C. J., Hartmann, L. C., Goodman, K., Maurer, M. J., Yu, C., Johnson, E. M., Erskine, C. L., Disis, M. L., Wettstein, P. J., Fikes, J. D., Beebe, M., Ishioka, G., Knutson, K. L. (2008). An HLA-DR-Degenerate Epitope Pool Detects Insulin-like Growth Factor Binding Protein 2-Specific Immunity in Patients with Cancer. Cancer Res. 68: 4893-4901 [Abstract] [Full Text]  
• Strowig, T., Brilot, F., Munz, C. (2008). Noncytotoxic Functions of NK Cells: Direct Pathogen Restriction and Assistance to Adaptive Immunity. J. Immunol. 180: 7785-7791 [Abstract] [Full Text]  
• Li, B., VanRoey, M., Triebel, F., Jooss, K. (2008). Lymphocyte Activation Gene-3 Fusion Protein Increases the Potency of a Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Cell Immunotherapy. Clin. Cancer Res. 14: 3545-3554 [Abstract] [Full Text]  
• Smyth, M. J., Teng, M. W.L., Sharkey, J., Westwood, J. A., Haynes, N. M., Yagita, H., Takeda, K., Sivakumar, P. V., Kershaw, M. H. (2008). Interleukin 21 Enhances Antibody-Mediated Tumor Rejection. Cancer Res. 68: 3019-3025 [Abstract] [Full Text]  
• Moeller, M., Kershaw, M. H., Cameron, R., Westwood, J. A., Trapani, J. A., Smyth, M. J., Darcy, P. K. (2007). Sustained Antigen-Specific Antitumor Recall Response Mediated by Gene-Modified CD4+ T Helper-1 and CD8+ T Cells. Cancer Res. 67: 11428-11437 [Abstract] [Full Text]  
• Sasaki, K., Zhu, X., Vasquez, C., Nishimura, F., Dusak, J. E., Huang, J., Fujita, M., Wesa, A., Potter, D. M., Walker, P. R., Storkus, W. J., Okada, H. (2007). Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors. Cancer Res. 67: 6451-6458 [Abstract] [Full Text]  
• Kobayashi, H., Nagato, T., Sato, K., Aoki, N., Kimura, S., Murakami, M., Iizuka, H., Azumi, M., Kakizaki, H., Tateno, M., Celis, E. (2007). Recognition of Prostate and Melanoma Tumor Cells by Six-Transmembrane Epithelial Antigen of Prostate-Specific Helper T Lymphocytes in a Human Leukocyte Antigen Class II-Restricted Manner. Cancer Res. 67: 5498-5504 [Abstract] [Full Text]  
• Zangani, M. M., Froyland, M., Qiu, G. Y., Meza-Zepeda, L. A., Kutok, J. L., Thompson, K. M., Munthe, L. A., Bogen, B. (2007). Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. JEM 204: 1181-1191 [Abstract] [Full Text]  
• Zhang, Y., Wakita, D., Chamoto, K., Narita, Y., Matsubara, N., Kitamura, H., Nishimura, T. (2007). Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs. Int Immunol 19: 151-161 [Abstract] [Full Text]  
• Jedema, I., Meij, P., Steeneveld, E., Hoogendoorn, M., Nijmeijer, B. A., van de Meent, M., van Luxemburg-Heijs, S. A.P., Willemze, R., Falkenburg, J.H. F. (2007). Early Detection and Rapid Isolation of Leukemia-Reactive Donor T Cells for Adoptive Transfer Using the IFN-{gamma} Secretion Assay. Clin. Cancer Res. 13: 636-643 [Abstract] [Full Text]  
• Xia, D., Hao, S., Xiang, J. (2006). CD8+ Cytotoxic T-APC Stimulate Central Memory CD8+ T Cell Responses via Acquired Peptide-MHC Class I Complexes and CD80 Costimulation, and IL-2 Secretion.. J. Immunol. 177: 2976-2984 [Abstract] [Full Text]  
• Willemsen, R. A., Sebestyen, Z., Ronteltap, C., Berrevoets, C., Drexhage, J., Debets, R. (2006). CD8{alpha} Coreceptor to Improve TCR Gene Transfer to Treat Melanoma: Down-Regulation of Tumor-Specific Production of IL-4, IL-5, and IL-10. J. Immunol. 177: 991-998 [Abstract] [Full Text]  
• Casati, C., Camisaschi, C., Rini, F., Arienti, F., Rivoltini, L., Triebel, F., Parmiani, G., Castelli, C. (2006). Soluble Human LAG-3 Molecule Amplifies the In vitro Generation of Type 1 Tumor-Specific Immunity.. Cancer Res. 66: 4450-4460 [Abstract] [Full Text]  
• van der Veken, L. T., Hagedoorn, R. S., van Loenen, M. M., Willemze, R., Falkenburg, J.H. F., Heemskerk, M. H.M. (2006). {alpha}{beta} T-Cell Receptor Engineered {gamma}{delta} T Cells Mediate Effective Antileukemic Reactivity.. Cancer Res. 66: 3331-3337 [Abstract] [Full Text]  
• Wakita, D., Chamoto, K., Zhang, Y., Narita, Y., Noguchi, D., Ohnishi, H., Iguchi, T., Sakai, T., Ikeda, H., Nishimura, T. (2006). An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. Int Immunol 18: 425-434 [Abstract] [Full Text]  
• Rohrer, J. W., Barsoum, A. L., Coggin, J. H. Jr. (2006). Identification of Oncofetal Antigen/Immature Laminin Receptor Protein Epitopes That Activate BALB/c Mouse OFA/iLRP-Specific Effector and Regulatory T Cell Clones.. J. Immunol. 176: 2844-2856 [Abstract] [Full Text]  
• Chamoto, K., Wakita, D., Narita, Y., Zhang, Y., Noguchi, D., Ohnishi, H., Iguchi, T., Sakai, T., Ikeda, H., Nishimura, T. (2006). An Essential Role of Antigen-Presenting Cell/T-Helper Type 1 Cell-Cell Interactions in Draining Lymph Node during Complete Eradication of Class II-Negative Tumor Tissue by T-Helper Type 1 Cell Therapy. Cancer Res. 66: 1809-1817 [Abstract] [Full Text]  
• Hiraoka, S.-i., Takeuchi, N., Bian, Y., Nakahara, H., Kogo, M., Dunussi-Joannopoulos, K., Wolf, S., Ono, S., Fujiwara, H. (2005). B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors. Int Immunol 17: 1071-1079 [Abstract] [Full Text]  
• Tsuji, T., Yasukawa, M., Matsuzaki, J., Ohkuri, T., Chamoto, K., Wakita, D., Azuma, T., Niiya, H., Miyoshi, H., Kuzushima, K., Oka, Y., Sugiyama, H., Ikeda, H., Nishimura, T. (2005). Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood 106: 470-476 [Abstract] [Full Text]  
• Xiang, J., Huang, H., Liu, Y. (2005). A New Dynamic Model of CD8+ T Effector Cell Responses via CD4+ T Helper-Antigen-Presenting Cells. J. Immunol. 174: 7497-7505 [Abstract] [Full Text]  
• Michael, A., Ball, G., Quatan, N., Wushishi, F., Russell, N., Whelan, J., Chakraborty, P., Leader, D., Whelan, M., Pandha, H. (2005). Delayed Disease Progression after Allogeneic Cell Vaccination in Hormone-Resistant Prostate Cancer and Correlation with Immunologic Variables. Clin. Cancer Res. 11: 4469-4478 [Abstract] [Full Text]  
• Reid, G. S. D., She, K., Terrett, L., Food, M. R., Trudeau, J. D., Schultz, K. R. (2005). CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response. Blood 105: 3641-3647 [Abstract] [Full Text]  
• Simmons, W. J., Koneru, M., Mohindru, M., Thomas, R., Cutro, S., Singh, P., DeKruyff, R. H., Inghirami, G., Coyle, A. J., Kim, B. S., Ponzio, N. M. (2005). Tim-3+ T-bet+ Tumor-Specific Th1 Cells Colocalize with and Inhibit Development and Growth of Murine Neoplasms. J. Immunol. 174: 1405-1415 [Abstract] [Full Text]  
• Suzuki, Y., Wakita, D., Chamoto, K., Narita, Y., Tsuji, T., Takeshima, T., Gyobu, H., Kawarada, Y., Kondo, S., Akira, S., Katoh, H., Ikeda, H., Nishimura, T. (2004). Liposome-Encapsulated CpG Oligodeoxynucleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity. Cancer Res. 64: 8754-8760 [Abstract] [Full Text]  
• Hoshino, A., Tsuji, T., Matsuzaki, J., Jinushi, T., Ashino, S., Teramura, T., Chamoto, K., Tanaka, Y., Asakura, Y., Sakurai, T., Mita, Y., Takaoka, A., Nakaike, S., Takeshima, T., Ikeda, H., Nishimura, T. (2004). STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int Immunol 16: 1497-1505 [Abstract] [Full Text]  
• Norris, P. J., Moffett, H. F., Yang, O. O., Kaufmann, D. E., Clark, M. J., Addo, M. M., Rosenberg, E. S. (2004). Beyond Help: Direct Effector Functions of Human Immunodeficiency Virus Type 1-Specific CD4+ T Cells. J. Virol. 78: 8844-8851 [Abstract] [Full Text]  
• Perez, O. D., Mitchell, D., Jager, G. C., Nolan, G. P. (2004). LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56+CD8+ natural killer cells. Blood 104: 1083-1093 [Abstract] [Full Text]  
• Bartholomae, W. C., Rininsland, F. H., Eisenberg, J. C., Boehm, B. O., Lehmann, P. V., Tary-Lehmann, M. (2004). T Cell Immunity Induced by Live, Necrotic, and Apoptotic Tumor Cells. J. Immunol. 173: 1012-1022 [Abstract] [Full Text]  
• Yamamoto, S., Tsuji, T., Matsuzaki, J., Zhange, Y., Chamoto, K., Kosaka, A., Togashi, Y., Sekikawa, K., Sawada, K.-i., Takeshima, T., Koike, T., Nishimura, T. (2004). Unexpected role of TNF-{alpha} in graft versus host reaction (GVHR): donor-derived TNF-{alpha} suppresses GVHR via inhibition of IFN-{gamma}-dependent donor type-1 immunity. Int Immunol 16: 811-817 [Abstract] [Full Text]  
• Gyobu, H., Tsuji, T., Suzuki, Y., Ohkuri, T., Chamoto, K., Kuroki, M., Miyoshi, H., Kawarada, Y., Katoh, H., Takeshima, T., Nishimura, T. (2004). Generation and Targeting of Human Tumor-Specific Tc1 and Th1 Cells Transduced with a Lentivirus Containing a Chimeric Immunoglobulin T-Cell Receptor. Cancer Res. 64: 1490-1495 [Abstract] [Full Text]  
• Yamaguchi, N., Hiraoka, S.-i., Mukai, T., Takeuchi, N., Zhou, X.-Y., Ono, S., Kogo, M., Dunussi-Joannopoulos, K., Ling, V., Wolf, S., Fujiwara, H. (2004). Induction of Tumor Regression by Administration of B7-Ig Fusion Proteins: Mediation by Type 2 CD8+ T Cells and Dependence on IL-4 Production. J. Immunol. 172: 1347-1354 [Abstract] [Full Text]  
• Dobrzanski, M. J., Reome, J. B., Hollenbaugh, J. A., Dutton, R. W. (2004). Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses. J. Immunol. 172: 1380-1390 [Abstract] [Full Text]  
• Chamoto, K., Tsuji, T., Funamoto, H., Kosaka, A., Matsuzaki, J., Sato, T., Abe, H., Fujio, K., Yamamoto, K., Kitamura, T., Takeshima, T., Togashi, Y., Nishimura, T. (2004). Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells. Cancer Res. 64: 386-390 [Abstract] [Full Text]  
• Dobrzanski, M. J., Reome, J. B., Hollenbaugh, J. A., Hylind, J. C., Dutton, R. W. (2004). Effector Cell-Derived Lymphotoxin {alpha} and Fas Ligand, but not Perforin, Promote Tc1 and Tc2 Effector Cell-Mediated Tumor Therapy in Established Pulmonary Metastases. Cancer Res. 64: 406-414 [Abstract] [Full Text]  
• Schuler, T., Kornig, S., Blankenstein, T. (2003). Tumor Rejection by Modulation of Tumor Stromal Fibroblasts. JEM 198: 1487-1493 [Abstract] [Full Text]  
• Sato, M., Chamoto, K., Nishimura, T. (2003). A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells. Int Immunol 15: 837-843 [Abstract] [Full Text]  
• Sasaki, K., Tsuji, T., Jinushi, T., Matsuzaki, J., Sato, T., Chamoto, K., Togashi, Y., Koda, T., Nishimura, T. (2003). Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets. Int Immunol 15: 701-710 [Abstract] [Full Text]  
• Nakamori, M., Iwahashi, M., Nakamura, M., Ueda, K., Zhang, X., Yamaue, H. (2003). Intensification of Antitumor Effect by T Helper 1-dominant Adoptive Immunogene Therapy for Advanced Orthotopic Colon Cancer. Clin. Cancer Res. 9: 2357-2365 [Abstract] [Full Text]  
• Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., Parish, C. (2003). Immunotherapy of Cytotoxic T Cell-resistant Tumors by T Helper 2 Cells: An Eotaxin and STAT6-dependent Process. JEM 197: 387-393 [Abstract] [Full Text]  
• Slager, E. H., Borghi, M., van der Minne, C. E., Aarnoudse, C. A., Havenga, M. J. E., Schrier, P. I., Osanto, S., Griffioen, M. (2003). CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame. J. Immunol. 170: 1490-1497 [Abstract] [Full Text]  
• Katakai, T., Hara, T., Sugai, M., Gonda, H., Nambu, Y., Matsuda, E., Agata, Y., Shimizu, A. (2002). Chemokine-independent Preference for T-helper-1 Cells in Transendothelial Migration. J. Biol. Chem. 277: 50948-50958 [Abstract] [Full Text]  
• Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., Bukowski, R. M., Mueller-Berghaus, J., Kirkwood, J. M., Kwok, W. W., Storkus, W. J. (2002). Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma. JEM 196: 619-628 [Abstract] [Full Text]  
• Mashino, K., Sadanaga, N., Tanaka, F., Ohta, M., Yamaguchi, H., Mori, M. (2002). Effective Strategy of Dendritic Cell-based Immunotherapy for Advanced Tumor-bearing Hosts: the Critical Role of Th1-dominant Immunity. Molecular Cancer Therapeutics 1: 785-794 [Abstract] [Full Text]  
• Zarour, H. M., Maillere, B., Brusic, V., Coval, K., Williams, E., Pouvelle-Moratille, S., Castelli, F., Land, S., Bennouna, J., Logan, T., Kirkwood, J. M. (2002). NY-ESO-1 119-143 Is a Promiscuous Major Histocompatibility Complex Class II T-Helper Epitope Recognized by Th1- and Th2-Type Tumor-reactive CD4+ T Cells. Cancer Res. 62: 213-218 [Abstract] [Full Text]  
• Kemp, R. A., Ronchese, F. (2001). Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity. J. Immunol. 167: 6497-6502 [Abstract] [Full Text]  
• Liu, J., Anderson, B. E., Robert, M. E., McNiff, J. M., Emerson, S. G., Shlomchik, W. D., Shlomchik, M. J. (2001). Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease. Blood 98: 3367-3375 [Abstract] [Full Text]  
• Faries, M. B., Bedrosian, I., Xu, S., Koski, G., Roros, J. G., Moise, M. A., Nguyen, H. Q., Engels, F. H. C., Cohen, P. A., Czerniecki, B. J. (2001). Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development. Blood 98: 2489-2497 [Abstract] [Full Text]  
• Tanigawa, K., Takeshita, N., Craig, R. A., Phillips, K., Knibbs, R. N., Chang, A. E., Stoolman, L. M. (2001). Tumor-Specific Responses in Lymph Nodes Draining Murine Sarcomas Are Concentrated in Cells Expressing P-Selectin Binding Sites. J. Immunol. 167: 3089-3098 [Abstract] [Full Text]  
• Pilon, S. A., Piechocki, M. P., Wei, W.-Z. (2001). Vaccination with Cytoplasmic ErbB-2 DNA Protects Mice from Mammary Tumor Growth Without Anti-ErbB-2 Antibody. J. Immunol. 167: 3201-3206 [Abstract] [Full Text]  
• Takaoka, A., Tanaka, Y., Tsuji, T., Jinushi, T., Hoshino, A., Asakura, Y., Mita, Y., Watanabe, K., Nakaike, S., Togashi, Y., Koda, T., Matsushima, K., Nishimura, T. (2001). A Critical Role for Mouse CXC Chemokine(s) in Pulmonary Neutrophilia During Th Type 1-Dependent Airway Inflammation. J. Immunol. 167: 2349-2353 [Abstract] [Full Text]  
• Meyer zum Buschenfelde, C., Metzger, J., Hermann, C., Nicklisch, N., Peschel, C., Bernhard, H. (2001). The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells. J. Immunol. 167: 1712-1719 [Abstract] [Full Text]  
• Dobrzanski, M. J., Reome, J. B., Dutton, R. W. (2001). Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection. J. Immunol. 167: 424-434 [Abstract] [Full Text]  
• Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M. J., Schofield, B. H., Hill, S. L., Rose, N. R. (2001). Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 Phenotype. Am. J. Pathol. 159: 193-203 [Abstract] [Full Text]  
• Beatty, G. L., Paterson, Y. (2001). IFN-{{gamma}}-Dependent Inhibition of Tumor Angiogenesis by Tumor-Infiltrating CD4+ T Cells Requires Tumor Responsiveness to IFN-{{gamma}}. J. Immunol. 166: 2276-2282 [Abstract] [Full Text]  
• Candido, K. A., Shimizu, K., McLaughlin, J. C., Kunkel, R., Fuller, J. A., Redman, B. G., Thomas, E. K., Nickoloff, B. J., Mulé, J. J. (2001). Local Administration of Dendritic Cells Inhibits Established Breast Tumor Growth: Implications for Apoptosis-inducing Agents. Cancer Res. 61: 228-236 [Abstract] [Full Text]  
• Ebner, S., Ratzinger, G., Krosbacher, B., Schmuth, M., Weiss, A., Reider, D., Kroczek, R. A., Herold, M., Heufler, C., Fritsch, P., Romani, N. (2001). Production of IL-12 by Human Monocyte-Derived Dendritic Cells Is Optimal When the Stimulus Is Given at the Onset of Maturation, and Is Further Enhanced by IL-4. J. Immunol. 166: 633-641 [Abstract] [Full Text]  
• Dalyot-Herman, N., Bathe, O. F., Malek, T. R. (2000). Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC. J. Immunol. 165: 6731-6737 [Abstract] [Full Text]  
• Fallarino, F., Grohmann, U., Bianchi, R., Vacca, C., Fioretti, M. C., Puccetti, P. (2000). Th1 and Th2 Cell Clones to a Poorly Immunogenic Tumor Antigen Initiate CD8+ T Cell-Dependent Tumor Eradication In Vivo. J. Immunol. 165: 5495-5501 [Abstract] [Full Text]  
• Beatty, G. L., Paterson, Y. (2000). IFN-{gamma} Can Promote Tumor Evasion of the Immune System In Vivo by Down-Regulating Cellular Levels of an Endogenous Tumor Antigen. J. Immunol. 165: 5502-5508 [Abstract] [Full Text]  
• Grohmann, U., Bianchi, R., Belladonna, M. L., Silla, S., Fallarino, F., Fioretti, M. C., Puccetti, P. (2000). IFN-{gamma} Inhibits Presentation of a Tumor/Self Peptide by CD8{alpha}- Dendritic Cells Via Potentiation of the CD8{alpha}+ Subset. J. Immunol. 165: 1357-1363 [Abstract] [Full Text]  
• Ohta, A., Sekimoto, M., Sato, M., Koda, T., Nishimura, S.-i., Iwakura, Y., Sekikawa, K., Nishimura, T. (2000). Indispensable Role for TNF-{alpha} and IFN-{gamma} at the Effector Phase of Liver Injury Mediated by Th1 Cells Specific to Hepatitis B Virus Surface Antigen. J. Immunol. 165: 956-961 [Abstract] [Full Text]  
• Fujio, K., Misaki, Y., Setoguchi, K., Morita, S., Kawahata, K., Kato, I., Nosaka, T., Yamamoto, K., Kitamura, T. (2000). Functional Reconstitution of Class II MHC-Restricted T Cell Immunity Mediated by Retroviral Transfer of the {alpha}{beta} TCR Complex. J. Immunol. 165: 528-532 [Abstract] [Full Text]  
• Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P., Cannon, M. J. (2000). Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes. J. Virol. 74: 4729-4737 [Abstract] [Full Text]  
• Egeter, O., Mocikat, R., Ghoreschi, K., Dieckmann, A., Röcken, M. (2000). Eradication of Disseminated Lymphomas with CpG-DNA Activated T Helper Type 1 Cells from Nontransgenic Mice. Cancer Res. 60: 1515-1520 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS